Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Expert Review of Pharmacoeconomics & Outcomes Research|February 23, 2023
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approachStefano Capri, Fernando Antoñanzas, Rosella LevaggiJournal of Medical Economics|October 9, 2009
Cost effectiveness of palivizumab in children with congenital heart disease in GermanyMark Nuijten, Maximilian Lebmeier, Wolfgang WittenbergClinicoeconomics and Outcomes Research : CEOR|December 19, 2013
Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgiaHiltrud Liedgens, Marko Obradovic, Mark NuijtenClinical Drug Investigation|January 14, 2010
Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysisMark Ritchie, Hiltrud Liedgens, Mark NuijtenJournal of Medical Economics|October 9, 2009
Cost effectiveness of palivizumab for RSV prevention in high-risk children in the NetherlandsMark Nuijten, Maximilian Lebmeier, Wolfgang WittenbergClinical Therapeutics|February 13, 2017
Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service PerspectiveStefano Capri, Camillo Porta, Thomas E DeleaJournal of Medical Economics|March 25, 2014
The application of economics concepts to stratified medicine--use of health economics data to support market access for stratified medicine interventionsHans-Joerg Fugel, Mark Nuijten, Eric FaulknerNew Biotechnology|September 25, 2016
Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environmentHans-Joerg Fugel, Mark Nuijten, Maarten PostmaBMC Health Services Research|October 10, 2014
An economic assessment of embryo diagnostics (Dx) - the costs of introducing non-invasive embryo diagnostics into IVF standard treatment practicesHans-Joerg Fugel, Mark Connolly, Mark NuijtenClinical Therapeutics|September 20, 2006
Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in GermanyReinhard Sittl, Mark Nuijten, Barbara Poulsen NautrupPageof 8